Cellular Longevity • Immune & Inflammation
Thymosin Alpha-1 — immune-modulating peptide for chronic infection research.
Tα1 is a 28-amino-acid peptide secreted by the thymus that matures T-cells and shifts the immune response toward Th1. Used clinically in 35+ countries for hepatitis, sepsis adjunct and oncology support.
Each PeptidePen is filled in a controlled cleanroom and sealed with tamper-evident packaging. Batch documentation includes identity confirmation, HPLC purity analysis and concentration verification. Strictly for in-vitro research — not for human or veterinary use.
A full breakdown of mechanism, clinical findings, dosing references and safety signals — for researchers who want the complete picture.
is a naturally occurring peptide associated with the proper functioning of the immune system. It is produced by thymic cells and plays an important role in supporting immune signaling and cellular communication processes within the body.
Thymosin Alpha 1 is involved in maintaining normal immune activity and supporting the function of various immune cells. It is being explored for its role in helping the body respond to external stressors, supporting immune balance, and contributing to cellular maintenance processes.
Thymosin Alpha 1 is associated with:
Supporting immune cell signaling and coordination
Modulating immune system responses
Contributing to balanced inflammatory processes
Supporting cellular renewal and repair mechanisms
It is widely studied in the context of immune system regulation and resilience.
Thymosin Alpha 1 has been investigated in research settings related to:
Immune system modulation
Response to viral, bacterial, and other external challenges
Regulation of inflammatory pathways
Support of immune system balance in various conditions
Complementary approaches in immune-related protocols
It is also being explored for its potential role in supporting overall physiological balance and healthy aging processes.
Research observations suggest that Thymosin Alpha 1 may support:
Balanced immune responsiveness
Improved coordination of immune cell activity
Regulation of inflammatory signaling
Support for recovery and resilience
Contribution to cellular protection against oxidative stress
Support of the body's adaptive response mechanisms
Thymosin Alpha 1 has been studied in multiple clinical settings focusing on immune-related conditions. Findings suggest it may act as a supportive agent within broader therapeutic strategies. Its application should always be evaluated by a qualified specialist depending on individual context.
Usage may vary depending on individual protocols and goals. A commonly referenced range is 500–600 mcg per day, corresponding to approximately 20–24 units daily.
The dosing system allows precise adjustment via a rotating dial, where each unit corresponds to one increment.
Application is typically performed in areas such as the abdominal region or upper leg. It is recommended to wait approximately 10 seconds after delivery before removing the device from the skin and to rotate application areas.
A typical protocol duration is around 7 days, depending on the intended use.
1 pen = 200 units
Each unit contains 25 mcg Thymosin Alpha 1
One pen (5 mg total content) typically lasts around 10 days, depending on daily usage
1 unit = 25 mcg
10 units = 250 mcg
20 units = 500 mcg
24 units = 600 mcg
Thymosin Alpha 1 is generally well tolerated; however, individual responses may vary. Reported effects may include:
Mild headache
Muscle discomfort
Slight increase in body temperature
Local skin sensitivity or redness at the application site
If any unusual symptoms occur, consultation with a qualified professional is recommended.
Enhances T-cell maturation and NK activity
Shifts Th2-dominant profiles toward Th1
Studied for chronic viral infections and cancer adjunct
Supports vaccine response in immunosenescence
Form
Pre-mixed pen
Purity
≥99% HPLC
Storage
2–8°C
Shipping
Cold-chain
COA
Batch-matched
Select pen size and shipping region at checkout.
Each batch is HPLC-assayed and documented.
Insulated, temperature-logged delivery.
Reference dosing and references included.
Common questions about Thymosin Alpha-1 and PeptidePen orders.
No. All PeptidePen products are strictly for in-vitro laboratory research. Not intended for human or veterinary use.
Each pen ships with a batch-matched certificate of analysis. A digital copy is also available on request via your order confirmation.
Orders ship cold-chain (2–8°C) with insulated packaging, ice packs and a temperature log. Tracked delivery in the US and EU.
Yes. Contact our team for institutional pricing, custom concentrations and recurring shipments.
Damaged or off-spec pens are replaced free of charge. Contact support within 7 days of delivery.
Pre-mixed, batch-assayed, cold-chain shipped — order before 2pm for same-day dispatch.
